She has also successfully expanded access to abortion medications and birth control
Expand access to abortion medications and birth control.
Occurrences
mifepristone is safe, effective, and must remain accessible
Evidence
legacy_unverified · Source version not recorded · locator unknown
Pressley led 250 House and Senate Democrats in filing an amicus brief asking the Supreme Court to overturn a Fifth Circuit ruling that would restrict access to mifepristone, the medication used for abortion, and argued that evidence-based access by mail or retail pharmacy should be preserved.
legacy_unverified · Source version not recorded · locator unknown
Pressley reintroduced the Reproductive Health Care Accessibility Act with Senators Murray and Duckworth to reduce barriers to reproductive health care for people with disabilities through provider training, accessibility improvements, and related supports; the page also notes gaps in contraception counseling.
legacy_unverified · Source version not recorded · locator unknown
Campaign issue page says Pressley has worked to protect abortion care and states that she has expanded access to abortion medications and birth control.
legacy_unverified · Source version not recorded · locator unknown
FDA says mifepristone may be dispensed in person or by mail, and that on January 3, 2023 it approved REMS modifications allowing certified pharmacies to dispense mifepristone on prescriptions from certified prescribers.
legacy_unverified · Source version not recorded · locator unknown
Pressley signed a letter asking FDA to lift the in-person dispensing requirement for mifepristone, arguing the requirement needlessly put patients and providers in harm's way and restricted access to medication abortion.
legacy_unverified · Source version not recorded · locator unknown
Pressley urged FDA to move quickly to make birth control available over the counter and said access must be affordable and available to everyone who needs it.
legacy_unverified · Source version not recorded · locator unknown
FDA approved Opill for nonprescription use to prevent pregnancy, the first daily oral contraceptive approved in the United States without a prescription, available in stores and online.
legacy_unverified · Source version not recorded · locator unknown
Pressley reintroduced the Affordability is Access Act to require insurers to fully cover over-the-counter birth control without fees or out-of-pocket costs once FDA deems an option safe.
legacy_unverified · Source version not recorded · locator unknown
Bill text states its purpose is timely access to affordable birth control by requiring coverage without cost-sharing for FDA-approved nonprescription contraceptives.
legacy_unverified · Source version not recorded · locator unknown
Congress.gov says H.R.3755 passed the House but Senate cloture was not invoked; the bill would bar limits on providers prescribing certain abortion drugs and offering abortion services via telemedicine.
legacy_unverified · Source version not recorded · locator unknown
The House Clerk records H.R.3755 as passed, 218-211, and lists Pressley, Democrat of Massachusetts, voting Yea.
legacy_unverified · Source version not recorded · locator unknown
Congress.gov lists H.R.12 as introduced and referred to committee; its summary says it would prohibit restrictions on abortion services, including use of abortion drugs and telemedicine.
legacy_unverified · Source version not recorded · locator unknown
Pressley introduced the Abortion Justice Act to address access to abortion care and create a vision where abortion care is readily available without systemic barriers.
legacy_unverified · Source version not recorded · locator unknown
The amicus brief lists Rep. Ayanna Pressley as a lead amicus and urges the Supreme Court to stay or vacate a Fifth Circuit order that would reinstate in-person dispensing requirements for mifepristone nationwide.
unverified · Source version 91382 · locator unknown
Pressley's House office says she and other congressional leaders led more than 250 Democrats in a Fifth Circuit amicus brief opposing Louisiana's effort to reinstate nationwide in-person dispensing requirements for mifepristone, which the release says would end telemedicine access and pharmacy dispensing for the abortion medication.
legacy_unverified · Source version not recorded · locator unknown
The Supreme Court docket records that a May 4, 2026 amicus brief by 259 Members of Congress was filed, and that on May 14, 2026 the Court stayed the Fifth Circuit's May 1 order in case 26-30203 pending the Fifth Circuit appeal and any timely certiorari proceedings.
Assessments
During Pressley's federal House service, access to both medication abortion and birth control expanded through federal action: FDA allowed mifepristone dispensing by mail and certified pharmacies, and FDA approved the first nonprescription daily oral contraceptive. Pressley also took relevant same-term actions, including urging FDA action on OTC birth control, signing/leading advocacy on mifepristone REMS and court access, and introducing or supporting bills aimed at abortion-medication and contraception access. Her role was not sole or legislative enactment, but the promise was broad and the federal outcomes occurred while she was in office with documented related advocacy from her.
Pressley materially advanced the goal through same-term legislative and litigation actions, including reintroducing the Reproductive Health Care Accessibility Act and leading an amicus brief defending mifepristone access. But the evidence shows advocacy and attempted expansion, not a completed federal policy change that actually expanded abortion-medication or birth-control access, so this is partial credit rather than full delivery.